Evaluation of the Effectiveness of vitamin D compared to metformin on letrozole Induced Polycystic Ovary Syndrome (PCOS) in Female Rats
Iranian Journal of Pharmaceutical Sciences,
Vol. 21 No. 1 (2025),
21 January 2025
,
Page 157-164
https://doi.org/10.22037/ijps.v21i1.46092
Abstract
Vitamin D is an old supplementation with a new mode of action as an encouraging alternative to current therapies for PCOS, and this research is designed to analyze the ability of vitamin D to rebalance hormonal abnormalities, antioxidant capacity, and ovarian morphology in letrozole-induced rats. Thirty-five female Sprague Dawley rats were used, and then they separated into five groups with seven animals each: the first group received only water, the second group received DMSO, the third group signed as PCOS group, Group IV received metformin, Group V received Topferol (vitamin D). PCOS was induced by administration of a daily dose of 1 mg per weight of letrozole for 21 days; after induction, the animals were treated with metformin and vitamin D for 19 days, and at the end of the experiment blood samples and ovarian tissues were taken for analysis. The results show that vitamin D normalized the estrus cycle in rats, restored the normal follicular development process, decreased the high levels of LH and testosterone, and enhanced the total antioxidant capacity. In conclusion, vitamin D is as effective as metformin in the reduction of several hormonal and biochemical features that are usually associated with PCOS mainly by restoring normal estrus cycle, renovating morphological features and folliculogenesis, and organizing abnormalities in hormone levels; however, it showed superior action regarding the antioxidative effect.
- Histopathology
- Infertility
- letrozole
- Metformin
- Polycystic Ovary Syndrome
- Vitamin D
How to Cite
References
Yousaf J, Khadija S, Ullah A. The chances of infertility in a patient presenting with PCOS in childbearing age. Saudi J Med (2022) 7(1): 15-21.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and sterility, 81(1), 19–25.
Caldwell A.S.L, Middleton L.J, Jimenez M, Desai R, McMahon A. C, Walters K.A. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology (2014) 155(8): 3146-3159.
Armeni E, Lambrinoudaki I. Cardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome. Current vascular pharmacology (2019) 17(6): 579–590.
Sahu P, Sharma N, Tsiatoura A. Pathophysiology of PCOS. A Guide to Hormonal Dermatology (2024) 73-79.
Itriyeva K. The normal menstrual cycle. Current problems in pediatric and adolescent health care (2022). 52(5): 101183.
Abdelazim I.A, Alanwar A. Zhurabekova G. Elevated and diagnostic androgens of polycystic ovary syndrome. Menopause Review/ Przegląd Menopauzalny (2020) 19(1):1-5.
McCartney C.R, Campbell R. E. Abnormal GnRH Pulsatility in Polycystic Ovary Syndrome: Recent Insights. Current opinion in endocrine and metabolic research (2020) 12:78–84.
Kanbour SA, Dobs AS. Hyperandrogenism in women with polycystic ovarian syndrome: pathophysiology and controversies. Androgens: Clinical Research and Therapeutics (2022) 3(1):22–30.
Schweighofer N. Lerchbaum E, Trummer O, Schwetz V, Pieber T, Obermayer-Pietsch B. Metformin resistance alleles in polcystic ovary syndrome: pattern and association with glucose metabolism. Pharmacogenomics (2014) 15(3): 305–317.
Shurrab N.T, Arafa E. S. A. Metformin: A review of its therapeutic efficacy and adverse effects. Obesity medicine (2020) 17:100186.
Guducu N, Gormus U, Dunder I. Hydroxyvitamin D levels are related to hyperinsulinemia in polycystic ovary syndrome. Gynecological Endocrinology (2014) 30 (8): 557-560.
Sander V.A, Hapon M.B, Sícaro L, Lombardi E.P, Jahn G.A, Motta A.B. Alterations of folliculogenesis in women with polycystic ovary syndrome. The Journal of Steroid Biochemistry and Molecular Biology (2011) 124 (1-2): 58-64.
Bahena-Alvarez D, Millan-Aldaco D, Rincón-Heredia R, Escamilla-Avila N, Hernandez-Cruz A. Expression of voltage-gated Ca2+ channels, Insp3Rs, and RyRs in the immature mouse ovary. Journal of ovarian research (2022) 15 (1):85. https://doi.org/10.1186/s13048-022-01015-y.
Rangsinth, P, Sharika R, Pattarachotanant N, Duangjan C, Wongwan, C, Chuchawankul S. Potential beneficial effects and pharmacological properties of ergosterol: A common bioactive compound in edible mushrooms. Foods (2023) 12 (13): 2529.
Karateke A, Dokuyucu R, Dogan, H, Ozgur T, Tas Z.A, Tumer C. Investigation of therapeutic effects of erdosteine on polycystic ovary syndrome in a rat model. Medical Principles and Practice (2019) 27 (6): 515-522.
Helal B. A.F, Ismail G.M, Zeid A.A.A. Effect of vitamin D on experimental model of polycystic ovary syndrome in female rats. Life sciences (2021) 283: 119558.
Lohrasbi P , Karbalay-Doust S, Mohammad Bagher Tabei S, Azarpira N, Alaee S, Bahmanpour S. The effects of melatonin and metformin on histological characteristics of the ovary and uterus in letrozole-induced polycystic ovarian syndrome mice: A stereological study. International journal of reproductive biomedicine (2022) 20 (11):973-988.
Ajayi A. F, Akhigbe R. E. Staging of the estrous cycle and induction of estrus in experimental rodents: an update. Fertility research and practice (2020) 6: 5.
Lovick T.A, Zangrossi H.Jr. Effect of Estrous Cycle on Behavior of Females in Rodent Tests of Anxiety. Frontiers in psychiatry (2021) 12: 711065.
Karateke A, Dokuyucu R, Dogan H, Ozgur T, Tas, Z.A, Tumer C. Investigation of therapeutic effects of erdosteine on polycystic ovary syndrome in a rat model. Medical Principles and Practice (2019) 27 (6): 515-522.
Mukherjee A.G, Wanjari U.R, Nagarajan D, Vibhaa K K, Anagha V, Gopalakrishnan A.V. Letrozole: Pharmacology: toxicity and potential therapeutic effects. Life Sciences (2022) 310: 121074.
Kyei G, Sobhani A, Nekonam S, Shabani M, Ebrahimi F, Fardin A. Assessing the effect of MitoQ10 and Vitamin D3 on ovarian oxidative stress, steroidogenesis and histomorphology in DHEA induced PCOS mouse model. Heliyon (2020) 6 (7).
Ghosh H, Rai S, Manzar M.D, Pandi-Perumal S.R, Brown G.M, Cardinali D.P. Differential expression and interaction of melatonin and thyroid hormone receptors with estrogen receptor α improve ovarian functions in letrozole-induced rat polycystic ovary syndrome. Life Sciences (2022) 295: 120086.
Younas A, Hussain L, Shabbir A, Asif M, Hussain M, Manzoor F. Effects of fagonia indica on letrozole‐induced polycystic ovarian syndrome (PCOS) in young adult female rats. Evidence‐Based Complementary and Alternative Medicine (2022 ) 1: 1397060.
Khosrowpour Z, Fahim S, Jafari, F, Tansaz, M., Sahranavard S, Faizi M. Beneficial effects of Teucrium polium hydroalcoholic extract on letrozole-induced polycystic ovary syndrome in rat model. Obstetrics & Gynecology Science (2023) 66 (2): 107.
Malini N.A, Roy G. K. Influence of Insulin on LH, Testosterone and SHBG in various PCOS Categories based on the Mode of Secretion of LH in relation to FSH Levels. Acta endocrinologica (Bucharest, Romania) (2005) 17 (3): 313–318.
Abulfadle K.A, Edrees H, Mohammed H.O. Spexin and Metformin Comparative Ameliorated Ovarian and Liver Function Changes in Letrozole-Induced Polycystic Ovary Syndrome in Rats (Histological, Biochemical, Immunohistochemical and Morphometric Study). Egyptian Journal of Histology (2022) 45 (3): 774-790.
Abdelsalam H.M, Hendawy, El-Sayed S.F. Copeptin as a Marker and Vitamin D as a Protector to Some Metabolic and Hormonal Changes in Both Lean and Obese Polycystic Ovary Syndrome Rat Model. Tobacco Regulatory Science (TRS) (2022) 1797-1820.
Bolamperti S, Villa I, Giustina A. The fine crosstalk between vitamin D and pituitary gland. Int J Bone Frag (2023) 3 (1): 2-6.
Gokosmanoglu F, Onmez A, Ergenç H. The relationship between Vitamin D deficiency and polycystic ovary syndrome. African health sciences (2020) 20 (4): 1880-1886.
Kurzthaler D, Hadziomerovic-Pekic D, Seeber B.E. Metformin induces a prompt decrease in LH-stimulated testosterone response in women with PCOS independent of its insulin-sensitizing effects. Reproductive Biology and Endocrinology (2014) 12:1-6.
Maliqueo M, Sun M, Johansson J, Benrick A, Labrie F, Stener-Victorin E. Continuous administration of a P450 aromatase inhibitor induces polycystic ovary syndrome with a metabolic and endocrine phenotype in female rats at adult age. Endocrinology (2013) 154 (1): 434-445.
Ayyadurai T, Thiruppathi S.K, Diana R.K..B. Effect of aqueous seed extract of Caesalpinia bonduc (L.) Roxb. on hormonal assay and lipid profile in induced polycystic ovary syndrome albino female rats. Int J Bot Stud (2021) 6 (3): 139-146.
González F, Nair K.S, Daniels J.K, Basal E, Schimke J.M, Blair H.E. Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidative stress in lean reproductive-age women. The Journal of clinical endocrinology and metabolism (2012) 97 (8): 2836-2843.
Blanco C.L, McGill-Vargas L.L , Gastaldelli A, Seidner, S.R, McCurnin D.C, Musi N. Peripheral insulin resistance and impaired insulin signaling contribute to abnormal glucose metabolism in preterm baboons. Endocrinology (2015) 156 (3): 813-823.
Rius-Pérez S, Torres-Cuevas I, Pérez S. PGC‐1α. inflammation, and oxidative stress: an integrative view in metabolism. Oxidative medicine and cellular longevity (2020) 1:1452696.
Elmosalamy S.H, Elleithy E.M, Ahmed Z.S.O, Rashad M.M, Ali G.E, Hassan N.H. Dysregulation of intraovarian redox status and steroid genesis pathway in letrozole-induced PCOS rat model: a possible modulatory role of l-Carnitine. Beni-Suef University Journal of Basic and Applied Sciences (2022) 11(1): 146.
Naseri L, Khazaei M.R., & Khazaei M. Potential Therapeutic Effect of Bee Pollen and Metformin Combination on Testosterone and Estradiol Levels, Apoptotic Markers and Total Antioxidant Capacity in A Rat Model of Polycystic Ovary Syndrome. International journal of fertility & sterility (2021) 15 (2) P: 101-107.
Janati S, Behmanesh M.A, Najafzadehvarzi H, Kassani A, Athari N, Poormoosavi S.M. Changes of Serum Level of Homocysteine and Oxidative Stress Markers by Metformin and Inositol in Infertile Women with Polycystic Ovary Syndrome: A Double Blind Randomized Clinical Trial Study. International journal of fertility & sterility (2022) 16 (2): 102-107.
Fatemi F, Mohammadzadeh A, Sadeghi M.R, Akhondi M.M, Mohammad moradi S, Giahi L. Role of vitamin E and D3 supplementation in Intra-Cytoplasmic Sperm Injection outcomes of women with polycystic ovarian syndrome: A double blinded randomized placebo-controlled trial. Clinical nutrition ESPEN (2017) 18: 23-30.
Jamilian M, Samimi M, Mirhosseini N, Afshar Ebrahimi F, Aghadavod E, Asemi Z. The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome. Journal of affective disorders (2018) 238: 32-38.
Rahsepar M, Mahjoub S, Ghasemi M. Evaluation of vitamin D status and its correlation with oxidative stress markers in women with polycystic ovary syndrome. International journal of reproductive biomedicine (2017) 15 (6): 345-350.
Zare-Mirzaie A, Kazeminezhad B, Akbari Ghouchani M. The Correlation Between Serum Vitamin D Level and Total Antioxidant Capacity in Diabetic and Non-Diabetic Subjects in Iran. Iranian journal of pathology (2018) 13 (2): 212-219.
Tanbo T, Mellembakken J, Bjercke S, Ring E, Abyholm T, Fedorcsak P. Ovulation induction in polycystic ovary syndrome. Acta obstetricia et gynecologica Scandinavica (2018) 97 (10): 1162-1167.
Rashid R, Tripathi R, Singh A, Sarkar S, Kawale A, Jha, R.K. Naringenin improves ovarian health by reducing the serum androgen and eliminating follicular cysts in letrozole-induced polycystic ovary syndrome in the Sprague Dawley rats. Phytotherapy research: PTR (2023) 37 (9):4018-4041.
Khaled N, El-Bahy A.A, AbdelMaksoud S. Ocimum kilimandscharicum L. restores ovarian functions in letrozole-induced Polycystic Ovary Syndrome (PCOS) in rats: Comparison with metformin. Life sciences (2019) 232: 116640.
[48] Rafiee B, Karbalay-Doust S, Tabei S.M.B, Azarpira, N, Alaee S, Bahmanpour S. Effects of N-acetyl cysteine and metformin treatment on the stereo pathological characteristics of uterus and ovary. European journal of translational myology (2022) 32 (2): 10409.
[49] Jahan, S., Abid, A., Khalid, S., Afsar, T., Qurat-Ul-Ain, & Razak, S. Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study. Journal of ovarian research, (2018) 11(1), 26.
[50] Kyei, G., Sobhani, A., Nekonam, S., Shabani, M., Ebrahimi, F., & Fardin, A. et al. Assessing the effect of MitoQ10 and Vitamin D3 on ovarian oxidative stress, steroidogenesis and histomorphology in DHEA induced PCOS mouse model. Heliyon (2020). 6(7).
- Abstract Viewed: 416 times
- IJPS_Volume21_Issue1_Pages157-164 Downloaded: 247 times